BNP Paribas Financial Markets
TTPH

BNP Paribas Financial Markets’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

BNP Paribas Financial Markets’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-372
Closed -$3.57K – 4575
2019
Q2 		$3.57K Sell
372
-231
-38% -$4.25K ﹤0.01% 4277
2019
Q1 		$16.2K Buy
603
+461
+325% +$11.7K ﹤0.01% 3953
2018
Q4 		$3.21K Buy
142
+49
+53% +$1.92K ﹤0.01% 3717
2018
Q3 		$5.13K Hold
93
– – ﹤0.01% 4050
2018
Q2 		$6.64K Sell
93
-478
-84% -$33.8K ﹤0.01% 3964
2018
Q1 		$35.1K Buy
571
+22
+4% +$1.93K ﹤0.01% 3730
2017
Q4 		$69.2K Buy
549
+374
+214% +$47.9K ﹤0.01% 3494
2017
Q3 		$23.9K Sell
175
-12
-6% -$1.6K ﹤0.01% 3506
2017
Q2 		$26.7K Buy
187
+182
+3,640% +$28.1K ﹤0.01% 3500
2017
Q1 		$827 Sell
5
-16
-76% -$1.79K ﹤0.01% 3742
2016
Q4 		$1.71K Sell
21
-102
-83% -$8.07K ﹤0.01% 3946
2016
Q3 		$9.4K Buy
123
+52
+73% +$4.17K ﹤0.01% 3189
2016
Q2 		$6.11K Buy
+71
New +$6.5K ﹤0.01% 3171
2016
Q1 		– Sell
-359
Closed -$72K – 3282
2015
Q4 		$72K Sell
359
-19
-5% -$3.79K ﹤0.01% 2551
2015
Q3 		$56.4K Buy
378
+226
+149% +$166K ﹤0.01% 2772
2015
Q2 		$145K Buy
152
+121
+390% +$98.9K ﹤0.01% 1891
2015
Q1 		$22.7K Buy
+31
New +$23.3K ﹤0.01% 2312
2014
Q4 		– Sell
-66
Closed -$26.4K – 3543
2014
Q3 		$26.4K Buy
66
+54
+450% +$14.5K ﹤0.01% 2972
2014
Q2 		$3.16K Buy
+12
New +$2.58K ﹤0.01% 2845
2014
Q1 		– Sell
-7
Closed -$2K – 3961
2013
Q4 		$2K Buy
+7
New +$1.67K ﹤0.01% 3652

Other funds holding TTPH

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BNP Paribas Financial Markets's TTPH Position: Q3 2019 in Review

BNP Paribas Financial Markets sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2019, closing a stake of 372 shares — an estimated $3.57K sold.

BNP Paribas Financial Markets first reported a position in TTPH in Q4 2013 and held it in 20 quarters. The position peaked at $145K in Q2 2015. 26 funds tracked by Wall St. Rank hold TTPH as of Q3 2019.

  • BNP Paribas Financial Markets reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 372 Tetraphase Pharmaceuticals, Inc. shares in Q3 2019, an estimated $3.57K.
  • BNP Paribas Financial Markets first reported a position in Tetraphase Pharmaceuticals, Inc. in Q4 2013 and held it in 20 quarters.
  • BNP Paribas Financial Markets's Tetraphase Pharmaceuticals, Inc. position peaked at $145K in Q2 2015.
  • 26 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2019.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2019, filed 7 Nov 2019.